IRIS
FIORILLO, BIANCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 166
EU - Europa 165
AS - Asia 87
AF - Africa 13
OC - Oceania 2
Totale 433
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 159
IT - Italia 142
SG - Singapore 65
CI - Costa d'Avorio 12
FR - Francia 8
MX - Messico 7
CN - Cina 6
FI - Finlandia 6
IN - India 5
VN - Vietnam 4
CZ - Repubblica Ceca 2
GB - Regno Unito 2
IE - Irlanda 2
IR - Iran 2
KR - Corea 2
MO - Macao, regione amministrativa speciale della Cina 2
AU - Australia 1
DE - Germania 1
EG - Egitto 1
HU - Ungheria 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
Totale 433
Salva come PNG Salva come JPEG
Città #
Naples 59
Singapore 50
Chandler 23
Ashburn 22
Torre Annunziata 11
Formia 9
Napoli 9
Santa Clara 8
Lawrence 6
Millbury 6
Boston 5
Dong Ket 4
Lappeenranta 4
Boardman 3
Cuernavaca 3
Langhirano 3
San Mateo 3
Vietri Sul Mare 3
Abidjan 2
Bhubaneswar 2
Bologna 2
Budrio 2
Des Moines 2
Dublin 2
Harlingen 2
Helsinki 2
Lucca 2
Macao 2
Perugia 2
Pozzuoli 2
Querétaro City 2
Salerno 2
Scafati 2
Xi'an 2
Auckland 1
Brno 1
Caposele 1
Chuncheon 1
Delaware 1
Fairfield 1
Hackney 1
Los Angeles 1
Melito di Napoli 1
Milan 1
Newark 1
Perm 1
Pune 1
Přerov 1
San Nicola la Strada 1
Seattle 1
Seoul 1
Trieste 1
Turin 1
Visone 1
Washington 1
Wrestedt 1
Totale 285
Salva come PNG Salva come JPEG
Nome #
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 58
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain 57
The TBC1D31/praja2 complex controls primary ciliogenesis through PKA-directed OFD1 ubiquitylation 42
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders 41
Discovery of Bile Acid Derivatives as Potent ACE2 Activators by Virtual Screening and Essential Dynamics 40
Structural Basis for Developing Multitarget Compounds Acting on Cysteinyl Leukotriene Receptor 1 and G-Protein-Coupled Bile Acid Receptor 1 37
Expanding the Library of 1,2,4-Oxadiazole Derivatives: Discovery of New Farnesoid X Receptor (FXR) Antagonists/Pregnane X Receptor (PXR) Agonists 32
AI-assisted de novo design of selective k-opioid receptor antagonists for the treatment of opioid addiction 29
Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury 23
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 18
Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders” 15
Structural insights into the unexpected agonism of tetracyclic antidepressants at serotonin receptors 5-HT1eR and 5-HT1FR 14
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition 14
Allosteric communication across the μ-opioid receptor-Gi1 protein complex induced by ligands of varying efficacy 12
Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders 11
Computational characterization of the binding mode and mechanism of action of tricyclic small molecules at 5-HT1E and 5-HT1F receptors 11
Metadynamics simulations leveraged by statistical analyses and artificial intelligence-based tools to inform the discovery of G protein-coupled receptor ligands 10
Hijacking SARS-Cov-2/ACE2 receptor interaction by natural and semi-synthetic steroidal agents acting on functional pockets on receptor binding region 6
Totale 470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.400
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.400
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 7 3 2 2 0 1 7 7
2021/202245 3 0 0 0 1 1 3 6 0 5 10 16
2022/202386 10 5 2 7 7 8 7 9 17 3 7 4
2023/2024165 25 12 12 13 6 7 4 14 4 5 44 19
2024/2025145 38 40 24 17 26 0 0 0 0 0 0 0
Totale 470